Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells

Leukemia & Lymphoma
G J KaspersA J Veerman

Abstract

Several clinical and cell biological features, such as sex, age, leukemic cell burden, morphologic FAB type, and immunophenotype, have prognostic value in childhood acute lymphoblastic leukemia (ALL). The explanation for their prognostic significance is unclear, but might be related to cellular drug resistance. We prospectively studied the relation between the above mentioned features with resistance to 13 drugs in 144 childhood ALL samples obtained at initial diagnosis. The MTT assay was used for drug resistance testing. The interindividual differences in drug resistance were very large and exceeded those between the several subgroups. There was generally no significant relation between sex, leukemic cell burden, and FAB type with drug resistance. However, subgroups with a worse prognosis as defined by age (< 18 months and > 120 months at diagnosis) or immunophenotype (pro-B ALL and T-ALL) did show relatively resistant drug resistance profiles as compared to the subgroups with a better prognosis (age 18-120 months, common and pre-B ALL). Within the group of common and pre-B ALL and compared to the intermediate age-group, samples of the younger children were significantly more resistant to daunorubicin, mitoxantrone and tenipos...Continue Reading

References

Aug 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G D Hammond
Jan 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K NooterA Hagenbeek
Apr 1, 1990·British Journal of Haematology·A J Veerman, R Pieters
Aug 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S C RaimondiG K Rivera
Oct 1, 1989·Pediatric Clinics of North America·W E EvansM Sunderland
Aug 1, 1989·British Journal of Cancer·J M Sargent, C G Taylor
Feb 1, 1989·British Journal of Haematology·J S Lilleyman, R F Hinchliffe
Aug 1, 1988·Pediatric Clinics of North America·D G Poplack, G Reaman
May 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E KokenbergB Löwenberg
Jan 1, 1986·Medical and Pediatric Oncology·D HammondS Siegel
Sep 1, 1994·Molecular Endocrinology·S Reisfeld, L Vardimon
Jan 1, 1993·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·E R van WeringJ J van Dongen

❮ Previous
Next ❯

Citations

Jan 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G Henze
Jan 1, 1997·Critical Reviews in Oncology/hematology·R PietersA J Veerman
May 5, 1999·Critical Reviews in Oncology/hematology·C E GiddingS S de Graaf
Dec 20, 2002·Current Opinion in Oncology·Yaddanapudi Ravindranath
Jun 27, 2002·Pediatric Research·Ellis GroningerSiebold de Graaf
Nov 3, 2005·Leukemia & Lymphoma·Monika M TreboHelmut Gadner
Feb 12, 2014·Expert Opinion on Drug Metabolism & Toxicology·Rabih Said, Apostolia Maria Tsimberidou
Aug 28, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Dominique J P M StumpelRonald W Stam
Aug 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M L Den BoerG E Janka-Schaub
Apr 12, 2013·Experimental Hematology & Oncology·Fung Kwong-Lam, Chan Godfrey Chi-Fung
Dec 6, 2006·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·J F MataL G Tone

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.